A citation-based method for searching scientific literature

Jennifer T Loud, Ellen Burke Beckjord, Kathryn Nichols, June Peters, Ruthann Giusti, Mark H Greene. BMC Womens Health 2009
Times Cited: 8







List of co-cited articles
58 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ductal lavage for detection of cellular atypia in women at high risk for breast cancer.
W C Dooley, B M Ljung, U Veronesi, M Cazzaniga, R M Elledge, J A O'Shaughnessy, H M Kuerer, D T Hung, S A Khan, R F Phillips,[...]. J Natl Cancer Inst 2001
201
75

Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer?
Jennifer T Loud, Anne C M Thiébaut, Andrea D Abati, Armando C Filie, Kathryn Nichols, David Danforth, Ruthann Giusti, Sheila A Prindiville, Mark H Greene. Cancer Epidemiol Biomarkers Prev 2009
21
62

The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.
K Visvanathan, D Santor, S Z Ali, A Brewster, A Arnold, D K Armstrong, N E Davidson, K J Helzlsouer. Cancer Epidemiol Biomarkers Prev 2007
18
50

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
37


Ductal lavage of cancerous and unaffected breasts: procedure success rate and cancer detection.
Marie E Wood, Mary A Stanley, Abigail M Crocker, Fonda S Kingsley, Gladwyn Leiman. Acta Cytol 2009
5
60

Reproducibility of cytologic atypia in repeat nipple duct lavage.
April Johnson-Maddux, Raheela Ashfaq, Leslie Cler, Elizabeth Naftalis, Ann Marilyn Leitch, Susan Hoover, David M Euhus. Cancer 2005
20
37

Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women.
Deepa B Patil, Heather A Lankes, Ritu Nayar, Shahla Masood, Michelle Bryk, Nanjiang Hou, Alfred Rademaker, Seema A Khan. Breast Cancer Res Treat 2008
20
37

Ductal lavage is an inefficient method of biomarker measurement in high-risk women.
Seema A Khan, Heather A Lankes, Deepa B Patil, Michele Bryk, Nanjiang Hou, David Ivancic, Ritu Nayar, Shahla Masood, Alfred Rademaker. Cancer Prev Res (Phila) 2009
13
37

Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk.
E R Sauter, E Ross, M Daly, A Klein-Szanto, P F Engstrom, A Sorling, J Malick, H Ehya. Br J Cancer 1997
153
37

Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model.
C J Fabian, B F Kimler, C M Zalles, J R Klemp, S Kamel, S Zeiger, M S Mayo. J Natl Cancer Inst 2000
206
37

Mammography of breast carcinoma in women who have mutations of the breast cancer gene BRCA1: initial experience.
M A Helvie, M A Roubidoux, B L Weber, S D Merajver. AJR Am J Roentgenol 1997
23
25

Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers.
Zhimin Huo, Maryellen L Giger, Olufunmilayo I Olopade, Dulcy E Wolverton, Barbara L Weber, Charles E Metz, Weiming Zhong, Shelly A Cummings. Radiology 2002
82
25

Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer.
Celine M Vachon, Thomas A Sellers, Erin E Carlson, Julie M Cunningham, Christopher A Hilker, Regenia L Smalley, Daniel J Schaid, Linda E Kelemen, Fergus J Couch, V Shane Pankratz. Cancer Res 2007
57
25

Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Gillian Mitchell, Antonis C Antoniou, Ruth Warren, Susan Peock, Judith Brown, Russell Davies, Jenny Mattison, Margaret Cook, Iqbal Warsi, D Gareth Evans,[...]. Cancer Res 2006
90
25

Mammographic breast density as a general marker of breast cancer risk.
Celine M Vachon, Kathleen R Brandt, Karthik Ghosh, Christopher G Scott, Shaun D Maloney, Michael J Carston, V Shane Pankratz, Thomas A Sellers. Cancer Epidemiol Biomarkers Prev 2007
142
25

Genetic models for the familial aggregation of mammographic breast density.
Masako Kataoka, Antonis Antoniou, Ruth Warren, Jean Leyland, Judith Brown, Tina Audley, Doug Easton. Cancer Epidemiol Biomarkers Prev 2009
17
25

Mammographic densities and breast cancer risk.
N F Boyd, G A Lockwood, J W Byng, D L Tritchler, M J Yaffe. Cancer Epidemiol Biomarkers Prev 1998
507
25

Heritability of mammographic density, a risk factor for breast cancer.
Norman F Boyd, Gillian S Dite, Jennifer Stone, Anoma Gunasekara, Dallas R English, Margaret R E McCredie, Graham G Giles, David Tritchler, Anna Chiarelli, Martin J Yaffe,[...]. N Engl J Med 2002
384
25

Computerized analysis of mammographic parenchymal patterns for assessing breast cancer risk: effect of ROI size and location.
Hui Li, Maryellen L Giger, Zhimin Huo, Olufunmilayo I Olopade, Li Lan, Barbara L Weber, Ioana Bonta. Med Phys 2004
45
25


Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma.
L J Hamilton, A J Evans, A R M Wilson, N Scott, E J Cornford, S E Pinder, H N Khan, R D Macmillan. Clin Radiol 2004
35
25

Preliminary sibpair linkage analysis of percent mammographic density.
C M Vachon, R A King, L D Atwood, C C Kuni, T A Sellers. J Natl Cancer Inst 1999
22
25

Familial influences on breast parenchymal patterns.
J N Wolfe, S Albert, S Belle, M Salane. Cancer 1980
30
25

Mammographic features and breast cancer risk: effects with time, age, and menopause status.
C Byrne, C Schairer, J Wolfe, N Parekh, M Salane, L A Brinton, R Hoover, R Haile. J Natl Cancer Inst 1995
649
25


Mammographic patterns in twin pairs discordant for breast cancer.
J Kaprio, A Alanko, L Kivisaari, C G Standertskjöld-Nordenstam. Br J Radiol 1987
27
25

Heritable aspects of dysplastic breast glandular tissue (DY).
G Haars, P A H van Noord, C H van Gils, P H M Peeters, D E Grobbee. Breast Cancer Res Treat 2004
8
25

Genetic analysis of mammographic breast density in adult women: evidence of a gene effect.
J S Pankow, C M Vachon, C C Kuni, R A King, D K Arnett, D M Grabrick, S S Rich, V E Anderson, T A Sellers. J Natl Cancer Inst 1997
100
25

A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography.
Madeleine Tilanus-Linthorst, Leon Verhoog, Inge-Marie Obdeijn, Karina Bartels, Marian Menke-Pluymers, Alexander Eggermont, Jan Klijn, Hanne Meijers-Heijboer, Theo van der Kwast, Cecile Brekelmans. Int J Cancer 2002
128
25

Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid.
M R Wrensch, N L Petrakis, E B King, R Miike, L Mason, K L Chew, M M Lee, V L Ernster, J F Hilton, R Schweitzer. Am J Epidemiol 1992
128
25

Breast-tissue sampling for risk assessment and prevention.
C J Fabian, B F Kimler, M S Mayo, S A Khan. Endocr Relat Cancer 2005
74
25

Directed duct excision by using mammary ductoscopy in patients with pathologic nipple discharge.
Jill R Dietz, Joseph P Crowe, Sharon Grundfest, Susana Arrigain, Julian A Kim. Surgery 2002
81
25


Combined breast ductal lavage and ductal endoscopy for the evaluation of the high-risk breast: a feasibility study.
David N Danforth, Andrea Abati, Armando Filie, Shiela A Prindiville, Diane Palmieri, Richard Simon, Thomas Ried, Patricia S Steeg. J Surg Oncol 2006
15
25

Nipple aspirate cytology for the study of breast cancer precursors.
E B King, K L Chew, N L Petrakis, V L Ernster. J Natl Cancer Inst 1983
76
25

Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.
Gertrude Case Buehring, Amy Letscher, Kathleen M McGirr, Shruti Khandhar, Lisa H Che, Christine T Nguyen, Adeline J Hackett. Breast Cancer Res Treat 2006
27
25

Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population.
Jeffrey A Tice, Rei Miike, Kelly Adduci, Nicholas L Petrakis, Eileen King, Margaret R Wrensch. Cancer Epidemiol Biomarkers Prev 2005
44
25

Epithelial cells in nipple aspirate fluid and subsequent breast cancer risk: a historic prospective study.
Kimberly A Baltzell, Michelle Moghadassi, Terri Rice, Jennette D Sison, Margaret Wrensch. BMC Cancer 2008
18
25

Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid.
M R Wrensch, N L Petrakis, R Miike, E B King, K Chew, J Neuhaus, M M Lee, M Rhys. J Natl Cancer Inst 2001
131
25

Patient and duct selection for nipple duct lavage.
April Johnson Maddux, Raheela Ashfaq, Elizabeth Naftalis, Ann Marilyn Leitch, Susan Hoover, David Euhus. Am J Surg 2004
15
25

Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer.
Deepa Bhandare, Ritu Nayar, Michele Bryk, Nanjiang Hou, Rachel Cohn, Nazar Golewale, Noah P Parker, Robert T Chatterton, Alfred Rademaker, Seema A Khan. Cancer Epidemiol Biomarkers Prev 2005
15
25

A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers.
Carol J Fabian, Bruce F Kimler, Deborah A Brady, Matthew S Mayo, C H Joseph Chang, John A Ferraro, Carola M Zalles, Annette L Stanton, Shahla Masood, William E Grizzle,[...]. Clin Cancer Res 2002
83
25

Ductal lavage findings in women with known breast cancer undergoing mastectomy.
Seema A Khan, Elizabeth L Wiley, Norma Rodriguez, Carol Baird, Rathi Ramakrishnan, Ritu Nayar, Michele Bryk, Kevin B Bethke, Valerie L Staradub, Judith Wolfman,[...]. J Natl Cancer Inst 2004
53
25

Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid.
Mary Jo Fackler, Kara Malone, Zhe Zhang, Eric Schilling, Elizabeth Garrett-Mayer, Theresa Swift-Scanlan, Julie Lange, Ritu Nayar, Nancy E Davidson, Seema A Khan,[...]. Clin Cancer Res 2006
98
25

Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways.
Catherine Ibarra-Drendall, Michelle M Troch, William T Barry, Gloria Broadwater, Emanuel F Petricoin, Julia Wulfkuhle, Lance A Liotta, Siya Lem, Joseph C Baker, Anne C Ford,[...]. Breast Cancer Res Treat 2012
17
25

Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
Anne-Renee Hartman, Bruce L Daniel, Allison W Kurian, Meredith A Mills, Kent W Nowels, Frederick M Dirbas, Kerry E Kingham, Nicki M Chun, Robert J Herfkens, James M Ford,[...]. Cancer 2004
58
25

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.
Elgene Lim, François Vaillant, Di Wu, Natasha C Forrest, Bhupinder Pal, Adam H Hart, Marie-Liesse Asselin-Labat, David E Gyorki, Teresa Ward, Audrey Partanen,[...]. Nat Med 2009
915
25

BRCA1 and BRCA2: different roles in a common pathway of genome protection.
Rohini Roy, Jarin Chun, Simon N Powell. Nat Rev Cancer 2011
726
25

Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer.
Gretchen L Gierach, Jennifer T Loud, Catherine K Chow, Sheila A Prindiville, Jennifer Eng-Wong, Peter W Soballe, Claudia Giambartolomei, Phuong L Mai, Claudia E Galbo, Kathryn Nichols,[...]. Breast Cancer Res Treat 2010
32
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.